Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 3:12:833-837.
doi: 10.2147/OPTH.S155631. eCollection 2018.

Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery

Affiliations

Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery

Ana Cláudia Viana Wanzeler et al. Clin Ophthalmol. .

Erratum in

Abstract

Purpose: Pterygium is a fibrovascular condition of the ocular surface that can cause a broad range of irritative and visual symptoms. Controversy exists regarding pterygium mechanisms, management, surgical techniques, adjuvant approaches and impact on patients' quality of life. We performed a retrospective survey focused on the impact of pterygium-related symptoms before surgery and patients' satisfaction after excision surgery followed by conjunctival autograft transplantation with fibrin glue, based on patients' subjective reporting.

Methods: All patients underwent surgery consisting of the extensive removal of the pterygium fibrovascular tissue, followed by autologous conjunctival graft fixed with fibrin glue to cover the bare scleral area. A total of 500 patients were contacted by phone call and invited to participate in the study answering a brief two-question survey. First, to grade overall intensity of symptoms related to pterygium before surgical intervention, such as pain, irritation, tearing, red eye, photophobia, burning and foreign body sensation, using a scale from 0 to 10 (0 asymptomatic and 10 very severe symptoms). Results were categorized as mild (0-3), moderate (4-7) and severe (8-10). Then, patients were asked about their satisfaction with the surgery outcome, also using a scale from 0 to 10 (ranging from dissatisfied to fully satisfied).

Results: Patients' mean age was 41.5±12.31 (min 18/max 83) years old and the mean of days after surgery was 1,493±552.7 (min 711/max 2,702). Symptoms were referred to as severe (70.2%), moderate (25.2%) and mild (4.6%). After surgery, most patients were fully satisfied and the mean grade was 9.6; 1% (0-3), 2.4% (4-7) and 96.6% (8-10). Women presented a higher score of symptoms compared to men (P<0.01) but similar satisfaction rates.

Conclusions: The present study shows that pterygium greatly impacts on patients' quality of life and that excision surgery using conjunctival autograft transplantation and fibrin glue improved symptoms with high rates of satisfaction.

Keywords: autologous conjunctival graft; fibrin glue; pterygium; quality of life; surgery; symptoms.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Illustrative example of surgical technique: pterygium removal followed by conjunctival autograft with fibrin glue fixation (A) before surgery, and (B) final appearance.
Figure 2
Figure 2
Illustrative example of final ocular surface appearance 3 months after pterigyum removal and autologous conjuntival graft. No recurrence.
Figure 3
Figure 3
Overall scores for preoperative symptoms (A) and postoperative satisfaction (B).
Figure 4
Figure 4
Preoperative symptoms (A) and postoperative satisfaction (B) according to sex.

Similar articles

Cited by

References

    1. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94(7):815–820. - PubMed
    1. Ang M, Li X, Wong W, et al. Prevalence of and racial differences in pterygium: a multiethnic population study in Asians. Ophthalmology. 2012;119(8):1509–1515. - PubMed
    1. Shiroma H, Higa A, Sawaguchi S, et al. Prevalence and risk factors of pterygium in a southwestern island of Japan: the Kumejima Study. Am J Ophthalmol. 2009;148(5):766–771.e1. - PubMed
    1. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open. 2013;3(11):e003787. - PMC - PubMed
    1. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48(2):145–180. - PubMed

LinkOut - more resources